• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1125250-15
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 03/01/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.The investigation determined the physical resistance and stent dislodgment appear to be related to the patient anatomy.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
It was reported that resistance was felt with the anatomy when advancing the 2.5x15 mm xience alpine stent delivery system (sds).While attempting to advance the sds, the stent dislodged in the patient anatomy.An unspecified xience alpine stent was implanted to complete the procedure.The following day, after the procedure, on (b)(6) 2017 a snare device was used to remove the dislodged stent from the patient anatomy.The patient is stable.There was a delay in the procedure, the patient had to have the dislodged stent snared two days after the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
(b)(4).The investigation determined the failure to advance appears to be related to the patient anatomy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key6412102
Report Number2024168-2017-02234
Device Sequence Number18970951
Product Code NIQ
UDI-Device Identifier08717648199165
UDI-Public(01)08717648199165(17)180308(10)5022641
Combination Product (Y/N)N
Initial Reporter StateWV
Initial Reporter CountryUS
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 05/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/08/2018
Device Catalogue Number1125250-15
Device Lot Number5022641
Was Device Available for Evaluation? No
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 03/02/2017
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date03/16/2017
Supplement Report FDA Received Date05/15/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age61 YR
Patient Weight83
-
-